Squamous Cell Carcinomas of the Tongue and Oral Cavity as Secondary Malignancies: What Factors Are Implicated?-Reference-Cited by-同舟云学术

Squamous Cell Carcinomas of the Tongue and Oral Cavity as Secondary Malignancies: What Factors Are Implicated?

Published:2013-03-01 Issue:3 Volume:18 Page:245-247
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Muggia Franco¹

Affiliation:

1. New York University Cancer Institute, New York, New York, USA

Abstract

The pegylated liposomal doxorubicin (PLD) was introduced clinically in the 1990s and won FDA approvals for the treatment of Kaposi's sarcoma (1995) and ovarian cancer (2000). At present, it seems prudent to engage patients in a discussion of risks (of a secondary cancer) versus benefits.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://pericles-gcp.literatumonline.com/doi/pdf/10.1634/theoncologist.2013-0021

Reference21 articles.

1. Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin;Hengge;Eur J Cancer,2001

2. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin;Martín-Carbonero;Clin Infect Dis,2008

3. Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer;Andreopoulou;Ann Oncol,2007

4. Delayed neoplastic and renal complications in women receiving long-term chemotherapy for recurrent ovarian cancer;Muggia;J Natl Cancer Inst,2011

5. Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer;Verschraegen;Ann Oncol,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up;Cancer Chemotherapy and Pharmacology;2020-02-13

2. Efficacy of pegylated liposomal doxorubicin maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective study;Archives of Gynecology and Obstetrics;2019-03-01

3. Oral leukoplakia, a precancerous lesion of squamous cell carcinoma, in patients with long-term pegylated liposomal doxorubicin treatment;Medicine;2018-02

4. The pattern of secondary cancers in patients with Kaposi sarcoma in the United States;Cancer Causes & Control;2017-09-12

5. Squamous Cell Carcinoma of the Oral Cavity in a Woman With a 9-Year History of Ovarian Cancer: Is Exposure to Pegylated Liposomal Doxorubicin a Factor?;The Oncologist;2014-03-25